ARENA PHARMACEUTICALS INC's ticker is ARNAXXXX and the CUSIP is 040047102. A total of 127 filers reported holding ARENA PHARMACEUTICALS INC in Q4 2014. The put-call ratio across all filers is 1.98 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2016 | $404,000 | -11.2% | 230,975 | +0.0% | 0.01% | -20.0% |
| Q1 2016 | $455,000 | +8.1% | 230,934 | +4.2% | 0.01% | 0.0% |
| Q4 2015 | $421,000 | -48.3% | 221,534 | +26.2% | 0.01% | -56.5% |
| Q2 2015 | $815,000 | -31.6% | 175,603 | -35.6% | 0.02% | -32.4% |
| Q1 2015 | $1,191,000 | +28.1% | 272,603 | +1.7% | 0.03% | +17.2% |
| Q4 2014 | $930,000 | -17.2% | 268,118 | 0.0% | 0.03% | -12.1% |
| Q3 2014 | $1,123,000 | +185.0% | 268,118 | +298.6% | 0.03% | +135.7% |
| Q2 2014 | $394,000 | -7.1% | 67,272 | 0.0% | 0.01% | -12.5% |
| Q1 2014 | $424,000 | +9.3% | 67,272 | +1.5% | 0.02% | 0.0% |
| Q4 2013 | $388,000 | +13.1% | 66,272 | +1.7% | 0.02% | +6.7% |
| Q3 2013 | $343,000 | -30.6% | 65,172 | +1.6% | 0.02% | -40.0% |
| Q2 2013 | $494,000 | – | 64,172 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Camber Capital Management LP | 10,500,000 | $17,955,000 | 0.87% |
| SENZAR ASSET MANAGEMENT, LLC | 1,872,191 | $3,201,447,000 | 0.70% |
| Virtus ETF Advisers LLC | 277,607 | $475,000 | 0.35% |
| GLOBEFLEX CAPITAL L P | 571,500 | $977,000 | 0.27% |
| Lyons Wealth Management, LLC. | 42,408 | $73,000 | 0.11% |
| TFS CAPITAL LLC | 222,736 | $381,000 | 0.07% |
| Jacobi Capital Management LLC | 35,000 | $56,000 | 0.03% |
| Renaissance Technologies | 5,601,355 | $9,578,000 | 0.02% |
| WELLINGTON MANAGEMENT GROUP LLP | 26,725,936 | $45,701,000 | 0.01% |
| PRELUDE CAPITAL MANAGEMENT, LLC | 46,300 | $79,000 | 0.01% |